These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 15125744)
1. Cytotoxic T lymphocyte count and survival time in women with metastatic breast cancer. Blake-Mortimer JS; Sephton SE; Carlson RW; Stites D; Spiegel D Breast J; 2004; 10(3):195-9. PubMed ID: 15125744 [TBL] [Abstract][Full Text] [Related]
2. Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Kuss I; Hathaway B; Ferris RL; Gooding W; Whiteside TL Clin Cancer Res; 2004 Jun; 10(11):3755-62. PubMed ID: 15173082 [TBL] [Abstract][Full Text] [Related]
3. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. Gao Q; Qiu SJ; Fan J; Zhou J; Wang XY; Xiao YS; Xu Y; Li YW; Tang ZY J Clin Oncol; 2007 Jun; 25(18):2586-93. PubMed ID: 17577038 [TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of circulating tumour cells enumerated after filtration enrichment in early and metastatic breast cancer patients. Wong NS; Kahn HJ; Zhang L; Oldfield S; Yang LY; Marks A; Trudeau ME Breast Cancer Res Treat; 2006 Sep; 99(1):63-9. PubMed ID: 16541316 [TBL] [Abstract][Full Text] [Related]
5. Circulating killer cells in women undergoing needle-directed excisional breast biopsy. Ohlsson-Wilhelm BM; Wang G Eur J Histochem; 1994; 38 Suppl 1():77-82. PubMed ID: 8547715 [TBL] [Abstract][Full Text] [Related]
6. Peripheral blood T cell subsets as a prognostic factor in gastric cancer. Ohwada S; Iino Y; Nakamura S; Takeyoshi I; Tanahashi Y; Izumi M; Kawashima Y; Arai M; Kobayashi I; Sato Y Jpn J Clin Oncol; 1994 Feb; 24(1):7-11. PubMed ID: 8126923 [TBL] [Abstract][Full Text] [Related]
7. Effect of bariatric surgery on peripheral blood lymphocyte subsets in women. Merhi ZO; Durkin HG; Feldman J; Macura J; Rodriguez C; Minkoff H Surg Obes Relat Dis; 2009; 5(2):165-71. PubMed ID: 18996763 [TBL] [Abstract][Full Text] [Related]
8. Ten years of experience with weekly chemotherapy in metastatic breast cancer patients: multivariate analysis of prognostic factors. Nisticò C; Cuppone F; Bria E; Fornier M; Giannarelli D; Mottolese M; Novelli F; Natoli G; Cognetti F; Terzoli E Anticancer Drugs; 2006 Nov; 17(10):1193-200. PubMed ID: 17075319 [TBL] [Abstract][Full Text] [Related]
9. Immune dysfunction and micrometastases in women with breast cancer. Campbell MJ; Scott J; Maecker HT; Park JW; Esserman LJ Breast Cancer Res Treat; 2005 May; 91(2):163-71. PubMed ID: 15868444 [TBL] [Abstract][Full Text] [Related]
10. [Breast-conservation treatment for early invasive breast cancer: prognostic factors for survival after salvage treatment of local recurrence]. Fodor J Magy Onkol; 2007; 51(2):127-31. PubMed ID: 17660868 [TBL] [Abstract][Full Text] [Related]
11. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217 [TBL] [Abstract][Full Text] [Related]
12. Lymphopenia: a new independent prognostic factor for survival in patients treated with whole brain radiotherapy for brain metastases from breast carcinoma. Claude L; Perol D; Ray-Coquard I; Petit T; Blay JY; Carrie C; Bachelot T Radiother Oncol; 2005 Sep; 76(3):334-9. PubMed ID: 16024123 [TBL] [Abstract][Full Text] [Related]
13. Rapid helper T-cell recovery above 200 x 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation. Kim DH; Sohn SK; Won DI; Lee NY; Suh JS; Lee KB Bone Marrow Transplant; 2006 Jun; 37(12):1119-28. PubMed ID: 16699530 [TBL] [Abstract][Full Text] [Related]
14. Brain metastases in breast cancer: prognostic factors and management. Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100 [TBL] [Abstract][Full Text] [Related]
15. Survival impact of integrative cancer care in advanced metastatic breast cancer. Block KI; Gyllenhaal C; Tripathy D; Freels S; Mead MN; Block PB; Steinmann WC; Newman RA; Shoham J Breast J; 2009; 15(4):357-66. PubMed ID: 19470134 [TBL] [Abstract][Full Text] [Related]
16. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial. Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ; J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000 [TBL] [Abstract][Full Text] [Related]
17. Body weight correlates with mortality in early-stage breast cancer. Enger SM; Greif JM; Polikoff J; Press M Arch Surg; 2004 Sep; 139(9):954-58; discussion 958-60. PubMed ID: 15381612 [TBL] [Abstract][Full Text] [Related]
18. Survival and breast relapse in 3834 patients with T1-T2 breast cancer after conserving surgery and adjuvant treatment. Livi L; Paiar F; Saieva C; Scoccianti S; Dicosmo D; Borghesi S; Agresti B; Nosi F; Orzalesi L; Santini R; Barca R; Biti GP Radiother Oncol; 2007 Mar; 82(3):287-93. PubMed ID: 17188382 [TBL] [Abstract][Full Text] [Related]
19. CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer. Okita R; Saeki T; Takashima S; Yamaguchi Y; Toge T Oncol Rep; 2005 Nov; 14(5):1269-73. PubMed ID: 16211295 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of immune subset measurement in individuals with AIDS-associated Kaposi's sarcoma. Stebbing J; Sanitt A; Teague A; Powles T; Nelson M; Gazzard B; Bower M J Clin Oncol; 2007 Jun; 25(16):2230-5. PubMed ID: 17470847 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]